Deal covers pre-poured media.

Eiken Chemical and bioMerieux signed an agreement by which some pre-poured media provided to bioMerieux customers in Japan will be replaced by those manufactured by Eiken.

“Since our foundation, we have been developing and offering reagents for microbiological investigation in order to prevent infectious diseases and food contamination. Today, we also develop and offer a wide range of in vitro diagnostic products and, specifically, culture media, which contribute to progress in public health,” says Tetsuya Teramoto, president and CEO of Eiken.

“We have now come to an agreement with bioMerieux, one of the largest global companies in this field, regarding service and distribution. This is a sign of recognition of the quality of our products on the Japanese market, and therefore, we will make every effort possible to ensure this collaboration is a success.”

Previous articleQiagen and Digene Merge in $1.6B Agreement
Next articleDanube Pharmaceuticals Taps Aptuit for Phase II Development Project